Deal before end of year?, page-51

As prospective buyers, interested in the company and proprietary IP with little interest in current share price growth, I can say that dilution of price and performance by management, low bars set in place for performance rights put in place by "friendly" major shareholders, is an ASX-wide problem. This is not unique to BRN and absolutely needs to be addressed at a statutory level. There needs to be a very hugh bar (e.g. 75% shareholder approval) for the granting of performance rights to directors or other major stakeholders. Only at a political level would this be effective, but it would take massive discontent market wide and possibly out of market pressure to prompt this change. The organisation I work with is interested in buying into BRN, but only at the right price - which is near enough to disclose our interest at this time.